COMPANY

Proneurogen, Inc

HQ: Tucson, AZ source · proneurogen.com ↗ · Southwest

Location: Tucson, AZ · source · Oct 15, 2026

Profile checked Oct 10, 2026

7NIH grants

Funding and NIH signals

NIH award NIH awarded $500K (SBIR Phase I 1R43AG099316-01, new, notice Sep 17, 2026). NIH RePORTER 1R43AG099316-01 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 1R43AG099316-01
  Organization: PRONEUROGEN, INC.; City/State: TUCSON, AZ; Project number: 1R43AG099316-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 499802; Administering IC: National Institute on Aging; Project title: Scale-up GMP Manufacturing of Extended-Release PNA5 for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular Dementia; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Sep 17, 2026 Grant Government grant — SBIR: $499,802 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NIA. Source: government award database. source ↗

Funding

Last 2 years.

Sep 17, 2026 Government grant — SBIR: $499,802 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NIA. Source: government award database. source ↗

NIH awards 7

Annual award amounts. Total $2.8M.

Sep 15, 2023 NIH award 1R43AG085713-01 FY2023: $499,545 awarded for that fiscal year; activity R43 (SBIR); PI RILEY, JEREMY; recipient as written: PRONEUROGEN, INC., TUCSON, AZ. GMP Manufacturing and IND Enabling Studies of Exten source ↗
Sep 20, 2022 NIH award 1R43AG077967-01A1 FY2022: $499,763 awarded for that fiscal year; activity R43 (SBIR); PI RILEY, JEREMY; recipient as written: PRONEUROGEN, INC., TUCSON, AZ. Extended-Release Formulation of Mas Receptor Agon source ↗
Aug 19, 2022 NIH award 1R43AG079647-01 FY2022: $499,598 awarded for that fiscal year; activity R43 (SBIR); PI RILEY, JEREMY; recipient as written: PRONEUROGEN, INC., TUCSON, AZ. Scale-up Manufacturing and IND Enabling Studies of source ↗
Aug 5, 2020 NIH award 1R43AG069524-01 FY2020: $439,355 awarded for that fiscal year; activity R43 (SBIR); PI OSSANNA, NINA; recipient as written: PRONEUROGEN, INC., TUCSON, AZ. Formulation of a Novel Therapeutic for Treating Cog source ↗
Sep 17, 2019 NIH award 1R43AG063674-01A1 FY2019: $449,886 awarded for that fiscal year; activity R43 (SBIR); PI OSSANNA, NINA; recipient as written: PRONEUROGEN, INC., TUCSON, AZ. Novel formulations of Allopregnanolone to treat A source ↗
Aug 29, 2019 NIH award 3R43AG063652-01S1 FY2019: $182,560 awarded for that fiscal year; activity R43 (SBIR); PI CROCKETT, TAMARA; recipient as written: PRONEUROGEN, INC., TUCSON, AZ. Microneedle Formulation for Treating Cognitive source ↗
Jun 13, 2019 NIH award 1R43AG063652-01 FY2019: $222,855 awarded for that fiscal year; activity R43 (SBIR); PI OSSANNA, NINA; recipient as written: PRONEUROGEN, INC., TUCSON, AZ. Microneedle Formulation for Treating Cognitive Impa source ↗